Galina Glazko
Concepts (313)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 16 | 2019 | 231 | 2.870 |
Why?
| Gene Expression Profiling | 15 | 2021 | 1138 | 1.950 |
Why?
| Gene Regulatory Networks | 7 | 2019 | 124 | 1.820 |
Why?
| Databases, Genetic | 8 | 2017 | 101 | 1.560 |
Why?
| Evolution, Molecular | 10 | 2012 | 103 | 1.540 |
Why?
| Transcriptome | 6 | 2021 | 346 | 1.450 |
Why?
| Colonic Neoplasms | 3 | 2019 | 164 | 1.280 |
Why?
| RNA | 4 | 2016 | 202 | 1.210 |
Why?
| Sequence Analysis, RNA | 6 | 2019 | 107 | 0.980 |
Why?
| Proteome | 3 | 2021 | 178 | 0.950 |
Why?
| Gene Expression | 6 | 2022 | 664 | 0.940 |
Why?
| DNA | 9 | 2013 | 581 | 0.940 |
Why?
| Oligonucleotide Array Sequence Analysis | 10 | 2017 | 474 | 0.930 |
Why?
| Genes, p53 | 4 | 2013 | 60 | 0.800 |
Why?
| Systems Biology | 2 | 2011 | 33 | 0.780 |
Why?
| Signal Transduction | 5 | 2019 | 1753 | 0.710 |
Why?
| Genes, Neoplasm | 1 | 2019 | 36 | 0.710 |
Why?
| Software | 5 | 2017 | 296 | 0.680 |
Why?
| Nuclear Matrix | 4 | 2003 | 6 | 0.660 |
Why?
| Consensus | 1 | 2019 | 157 | 0.660 |
Why?
| Colonic Polyps | 1 | 2017 | 43 | 0.610 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 206 | 0.600 |
Why?
| Phylogeny | 7 | 2010 | 269 | 0.570 |
Why?
| Adenoma | 1 | 2017 | 142 | 0.550 |
Why?
| Models, Genetic | 6 | 2008 | 209 | 0.540 |
Why?
| Genes, X-Linked | 1 | 2014 | 8 | 0.520 |
Why?
| Computer Simulation | 5 | 2017 | 332 | 0.500 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2012 | 50 | 0.430 |
Why?
| Models, Statistical | 3 | 2012 | 259 | 0.420 |
Why?
| Tumor Suppressor Protein p53 | 3 | 2017 | 250 | 0.410 |
Why?
| Disease | 1 | 2011 | 28 | 0.400 |
Why?
| Azospirillum brasilense | 2 | 2022 | 4 | 0.400 |
Why?
| Genome, Viral | 3 | 2008 | 100 | 0.390 |
Why?
| Bacteriophages | 2 | 2007 | 11 | 0.390 |
Why?
| Phenotype | 5 | 2017 | 820 | 0.390 |
Why?
| Animals | 23 | 2021 | 14385 | 0.380 |
Why?
| Humans | 35 | 2023 | 54246 | 0.370 |
Why?
| Base Sequence | 9 | 2013 | 719 | 0.360 |
Why?
| Algorithms | 4 | 2017 | 697 | 0.360 |
Why?
| Genome | 3 | 2013 | 74 | 0.350 |
Why?
| Gene Expression Regulation | 6 | 2017 | 1062 | 0.340 |
Why?
| Principal Component Analysis | 2 | 2019 | 71 | 0.330 |
Why?
| Neoplasms | 3 | 2005 | 1315 | 0.330 |
Why?
| Proteomics | 3 | 2021 | 343 | 0.320 |
Why?
| Biological Evolution | 2 | 2023 | 37 | 0.310 |
Why?
| Molecular Sequence Data | 8 | 2012 | 980 | 0.310 |
Why?
| Genetic Variation | 3 | 2009 | 253 | 0.300 |
Why?
| Germ-Line Mutation | 3 | 2005 | 68 | 0.300 |
Why?
| Cluster Analysis | 4 | 2017 | 249 | 0.290 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 182 | 0.290 |
Why?
| Chromosome Mapping | 2 | 2008 | 175 | 0.280 |
Why?
| Linkage Disequilibrium | 1 | 2005 | 47 | 0.270 |
Why?
| Proteins | 3 | 2014 | 376 | 0.270 |
Why?
| Multivariate Analysis | 3 | 2017 | 643 | 0.250 |
Why?
| Binding Sites | 4 | 2012 | 440 | 0.250 |
Why?
| Chromosomes | 2 | 2008 | 40 | 0.250 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 866 | 0.250 |
Why?
| Nucleotides | 3 | 2023 | 23 | 0.240 |
Why?
| Sequence Analysis, DNA | 5 | 2007 | 273 | 0.230 |
Why?
| DNA, Intergenic | 1 | 2003 | 6 | 0.230 |
Why?
| Primates | 1 | 2003 | 20 | 0.230 |
Why?
| Conserved Sequence | 1 | 2003 | 57 | 0.230 |
Why?
| Herbaspirillum | 1 | 2022 | 2 | 0.220 |
Why?
| Genomics | 3 | 2017 | 310 | 0.220 |
Why?
| Cecum | 2 | 2021 | 72 | 0.220 |
Why?
| Mutation | 5 | 2019 | 1501 | 0.210 |
Why?
| RNA, Messenger | 4 | 2019 | 1202 | 0.210 |
Why?
| Cell Cycle Proteins | 2 | 2017 | 199 | 0.210 |
Why?
| Cell Line, Tumor | 2 | 2017 | 1550 | 0.190 |
Why?
| Selection, Genetic | 3 | 2012 | 27 | 0.190 |
Why?
| Cell Nucleus | 2 | 2013 | 203 | 0.180 |
Why?
| Infant Formula | 1 | 2021 | 152 | 0.180 |
Why?
| RNA, Untranslated | 1 | 2019 | 17 | 0.180 |
Why?
| Reproducibility of Results | 4 | 2016 | 1304 | 0.180 |
Why?
| Sequence Alignment | 4 | 2007 | 146 | 0.170 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2013 | 58 | 0.170 |
Why?
| Ruminococcus | 1 | 2019 | 9 | 0.170 |
Why?
| Drosophila melanogaster | 2 | 2012 | 24 | 0.170 |
Why?
| Phosphoproteins | 2 | 2013 | 116 | 0.170 |
Why?
| Extracellular Matrix | 1 | 2019 | 111 | 0.170 |
Why?
| Profilins | 1 | 2018 | 18 | 0.170 |
Why?
| Starch | 1 | 2019 | 33 | 0.170 |
Why?
| Sample Size | 2 | 2015 | 48 | 0.160 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 39 | 0.160 |
Why?
| Pharmacogenetics | 1 | 2018 | 55 | 0.160 |
Why?
| Nuclear Proteins | 3 | 2006 | 252 | 0.160 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 64 | 0.160 |
Why?
| Hyperplasia | 1 | 2017 | 107 | 0.160 |
Why?
| Small Molecule Libraries | 1 | 2018 | 72 | 0.160 |
Why?
| GTP-Binding Proteins | 1 | 2017 | 94 | 0.150 |
Why?
| Chromatin | 2 | 2012 | 156 | 0.150 |
Why?
| Neurodegenerative Diseases | 1 | 2018 | 83 | 0.150 |
Why?
| Gene Amplification | 1 | 1997 | 57 | 0.150 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 99 | 0.150 |
Why?
| Diet | 1 | 2021 | 597 | 0.150 |
Why?
| DNA Helicases | 2 | 2016 | 132 | 0.150 |
Why?
| DNA Replication | 2 | 2016 | 152 | 0.150 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 151 | 0.150 |
Why?
| Lampreys | 2 | 2007 | 2 | 0.150 |
Why?
| Data Mining | 1 | 2017 | 38 | 0.150 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 136 | 0.140 |
Why?
| Protein Interaction Maps | 1 | 2016 | 24 | 0.140 |
Why?
| Down-Regulation | 1 | 2017 | 388 | 0.140 |
Why?
| Colorectal Neoplasms | 1 | 2019 | 235 | 0.140 |
Why?
| Protein Processing, Post-Translational | 1 | 2017 | 183 | 0.140 |
Why?
| Protein Interaction Mapping | 1 | 2016 | 44 | 0.140 |
Why?
| Up-Regulation | 1 | 2017 | 508 | 0.140 |
Why?
| Models, Theoretical | 1 | 2017 | 184 | 0.140 |
Why?
| Kidney | 1 | 2020 | 820 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 2017 | 359 | 0.130 |
Why?
| Mice | 5 | 2020 | 6413 | 0.130 |
Why?
| Bacterial Proteins | 1 | 2019 | 454 | 0.130 |
Why?
| Breast Neoplasms | 3 | 2021 | 1248 | 0.120 |
Why?
| Data Interpretation, Statistical | 2 | 2013 | 177 | 0.120 |
Why?
| Lymphocytes | 1 | 2014 | 168 | 0.120 |
Why?
| Adaptation, Physiological | 2 | 2012 | 101 | 0.120 |
Why?
| Lung Neoplasms | 1 | 2019 | 642 | 0.120 |
Why?
| Activating Transcription Factor 1 | 1 | 2013 | 23 | 0.120 |
Why?
| RNA Stability | 1 | 2013 | 28 | 0.120 |
Why?
| RNA, Fungal | 1 | 2013 | 30 | 0.110 |
Why?
| Schizosaccharomyces pombe Proteins | 1 | 2013 | 39 | 0.110 |
Why?
| Schizosaccharomyces | 1 | 2013 | 53 | 0.110 |
Why?
| RNA, Antisense | 1 | 2012 | 10 | 0.110 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 9 | 0.110 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 133 | 0.110 |
Why?
| RNA, Double-Stranded | 1 | 2012 | 21 | 0.110 |
Why?
| Tunica Intima | 1 | 2012 | 52 | 0.110 |
Why?
| Genomic Instability | 1 | 2013 | 95 | 0.110 |
Why?
| Ribosomal Proteins | 1 | 2012 | 31 | 0.110 |
Why?
| Carotid Arteries | 1 | 2012 | 82 | 0.110 |
Why?
| Genes | 2 | 2004 | 38 | 0.110 |
Why?
| Chromosome Disorders | 1 | 2012 | 39 | 0.110 |
Why?
| Amino Acid Sequence | 4 | 2008 | 767 | 0.110 |
Why?
| Disease Progression | 3 | 2020 | 913 | 0.110 |
Why?
| G-Quadruplexes | 1 | 2013 | 81 | 0.100 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 140 | 0.100 |
Why?
| Rats | 3 | 2019 | 3415 | 0.100 |
Why?
| Species Specificity | 2 | 2005 | 205 | 0.100 |
Why?
| Open Reading Frames | 3 | 2023 | 55 | 0.100 |
Why?
| Protein Array Analysis | 1 | 2010 | 28 | 0.100 |
Why?
| Gene Transfer, Horizontal | 2 | 2007 | 7 | 0.100 |
Why?
| Plant Roots | 2 | 2022 | 37 | 0.100 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 2003 | 59 | 0.100 |
Why?
| Saccharomyces cerevisiae | 2 | 2013 | 218 | 0.090 |
Why?
| Ethanol | 1 | 2012 | 322 | 0.090 |
Why?
| Periodicity | 1 | 2008 | 29 | 0.080 |
Why?
| Bacteria | 2 | 2021 | 258 | 0.080 |
Why?
| Thermus thermophilus | 1 | 2008 | 1 | 0.080 |
Why?
| Siphoviridae | 1 | 2008 | 1 | 0.080 |
Why?
| Cell Proliferation | 1 | 2012 | 1096 | 0.080 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2008 | 92 | 0.080 |
Why?
| Viral Proteins | 2 | 2008 | 158 | 0.080 |
Why?
| Male | 8 | 2020 | 27312 | 0.080 |
Why?
| Flow Cytometry | 1 | 2010 | 546 | 0.080 |
Why?
| Cytosine Deaminase | 1 | 2007 | 5 | 0.080 |
Why?
| Receptors, Antigen | 1 | 2007 | 2 | 0.080 |
Why?
| Globins | 3 | 2003 | 14 | 0.080 |
Why?
| Aryldialkylphosphatase | 1 | 2007 | 4 | 0.080 |
Why?
| DNA, Viral | 1 | 2008 | 142 | 0.080 |
Why?
| Nuclear Envelope | 1 | 2006 | 4 | 0.070 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2007 | 84 | 0.070 |
Why?
| Adaptation, Biological | 1 | 2005 | 9 | 0.070 |
Why?
| 5' Untranslated Regions | 2 | 2003 | 33 | 0.070 |
Why?
| Receptors, Immunologic | 1 | 2005 | 37 | 0.070 |
Why?
| Immunity | 1 | 2005 | 36 | 0.070 |
Why?
| Pan troglodytes | 1 | 2005 | 14 | 0.070 |
Why?
| Fossils | 1 | 2005 | 15 | 0.070 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 54 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2011 | 481 | 0.070 |
Why?
| Hominidae | 1 | 2005 | 16 | 0.070 |
Why?
| Likelihood Functions | 1 | 2005 | 61 | 0.060 |
Why?
| Calibration | 1 | 2005 | 59 | 0.060 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 170 | 0.060 |
Why?
| Mutation, Missense | 1 | 2005 | 117 | 0.060 |
Why?
| DNA, Neoplasm | 1 | 2005 | 171 | 0.060 |
Why?
| Gene Expression Regulation, Archaeal | 1 | 2004 | 1 | 0.060 |
Why?
| Genes, Archaeal | 1 | 2004 | 3 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2004 | 105 | 0.060 |
Why?
| Chickens | 1 | 2005 | 118 | 0.060 |
Why?
| Eukaryotic Cells | 1 | 2004 | 20 | 0.060 |
Why?
| Genes, Fungal | 1 | 2004 | 39 | 0.060 |
Why?
| Octopamine | 1 | 2004 | 1 | 0.060 |
Why?
| Inheritance Patterns | 1 | 2004 | 27 | 0.060 |
Why?
| Statistics as Topic | 1 | 2004 | 103 | 0.060 |
Why?
| Genes, Bacterial | 1 | 2004 | 67 | 0.060 |
Why?
| CpG Islands | 1 | 2004 | 104 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2004 | 85 | 0.060 |
Why?
| Quality Control | 1 | 2004 | 101 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2007 | 552 | 0.060 |
Why?
| Membrane Proteins | 1 | 2006 | 389 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2020 | 1639 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2004 | 141 | 0.060 |
Why?
| DNA Topoisomerases, Type I | 1 | 2003 | 3 | 0.060 |
Why?
| Trans-Activators | 1 | 2004 | 147 | 0.060 |
Why?
| DNA Topoisomerases, Type II | 1 | 2003 | 16 | 0.060 |
Why?
| Time | 1 | 2003 | 36 | 0.060 |
Why?
| Genome, Bacterial | 1 | 2004 | 141 | 0.060 |
Why?
| DNA Transposable Elements | 1 | 2003 | 82 | 0.060 |
Why?
| Dopamine | 1 | 2004 | 190 | 0.060 |
Why?
| Myocardial Infarction | 1 | 2007 | 424 | 0.060 |
Why?
| Immunoglobulins | 1 | 2003 | 89 | 0.050 |
Why?
| Female | 5 | 2021 | 28418 | 0.050 |
Why?
| Protein Binding | 2 | 2006 | 736 | 0.050 |
Why?
| Plants | 1 | 2002 | 55 | 0.050 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2004 | 244 | 0.050 |
Why?
| DNA, Plant | 1 | 2001 | 7 | 0.050 |
Why?
| DNA-Binding Proteins | 1 | 2004 | 462 | 0.050 |
Why?
| Telomere | 1 | 2001 | 36 | 0.050 |
Why?
| Models, Animal | 1 | 2021 | 255 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2007 | 570 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 51 | 0.050 |
Why?
| Nucleic Acid Conformation | 2 | 2013 | 99 | 0.050 |
Why?
| Milk, Human | 1 | 2021 | 109 | 0.050 |
Why?
| Transcription Factors | 1 | 2004 | 622 | 0.050 |
Why?
| Animals, Newborn | 1 | 2021 | 396 | 0.050 |
Why?
| Swine | 1 | 2021 | 431 | 0.050 |
Why?
| Antigens, Nuclear | 1 | 2000 | 24 | 0.050 |
Why?
| Decision Trees | 1 | 2019 | 26 | 0.050 |
Why?
| RNA, Plant | 1 | 2019 | 8 | 0.040 |
Why?
| Genes, Plant | 1 | 2019 | 16 | 0.040 |
Why?
| Symbiosis | 1 | 2019 | 11 | 0.040 |
Why?
| Gene Expression Regulation, Plant | 1 | 2019 | 50 | 0.040 |
Why?
| Li-Fraumeni Syndrome | 1 | 1999 | 13 | 0.040 |
Why?
| Exons | 1 | 1999 | 105 | 0.040 |
Why?
| Motor Neurons | 1 | 2018 | 31 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 151 | 0.040 |
Why?
| Neuroglia | 1 | 2018 | 52 | 0.040 |
Why?
| Cell Cycle | 2 | 2012 | 275 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 1999 | 477 | 0.040 |
Why?
| Artiodactyla | 1 | 1997 | 1 | 0.040 |
Why?
| Perissodactyla | 1 | 1997 | 1 | 0.040 |
Why?
| Electrophoresis, Agar Gel | 1 | 1997 | 12 | 0.040 |
Why?
| Random Amplified Polymorphic DNA Technique | 1 | 1997 | 4 | 0.040 |
Why?
| Spinal Cord | 1 | 2018 | 151 | 0.040 |
Why?
| Time Factors | 1 | 2005 | 3212 | 0.040 |
Why?
| Protein Isoforms | 1 | 2017 | 124 | 0.040 |
Why?
| DNA Primers | 1 | 1997 | 225 | 0.040 |
Why?
| Genetic Markers | 1 | 1997 | 117 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2000 | 1048 | 0.040 |
Why?
| Mice, Transgenic | 1 | 2018 | 656 | 0.040 |
Why?
| Phosphorylation | 1 | 2017 | 614 | 0.030 |
Why?
| MicroRNAs | 1 | 2019 | 386 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 823 | 0.030 |
Why?
| Prognosis | 1 | 2021 | 2118 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 684 | 0.030 |
Why?
| DNA Repair | 1 | 2016 | 202 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2019 | 1663 | 0.030 |
Why?
| Cell Line | 1 | 2017 | 1153 | 0.030 |
Why?
| Research Design | 1 | 2016 | 374 | 0.030 |
Why?
| Genome, Mitochondrial | 1 | 2013 | 11 | 0.030 |
Why?
| Tunica Media | 1 | 2012 | 11 | 0.030 |
Why?
| S Phase | 1 | 2012 | 19 | 0.030 |
Why?
| G1 Phase | 1 | 2012 | 19 | 0.030 |
Why?
| Lod Score | 1 | 2012 | 7 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 82 | 0.030 |
Why?
| Genes, Insect | 1 | 2012 | 7 | 0.030 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2013 | 78 | 0.030 |
Why?
| Larva | 1 | 2012 | 23 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 31 | 0.030 |
Why?
| Microarray Analysis | 1 | 2012 | 84 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 198 | 0.030 |
Why?
| Bayes Theorem | 1 | 2012 | 123 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2012 | 136 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 2003 | 92 | 0.030 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 105 | 0.030 |
Why?
| Internet | 1 | 2012 | 275 | 0.020 |
Why?
| Prostatic Neoplasms | 1 | 2013 | 415 | 0.020 |
Why?
| Mitochondria | 1 | 2013 | 489 | 0.020 |
Why?
| Cells, Cultured | 1 | 2012 | 1737 | 0.020 |
Why?
| Virion | 1 | 2008 | 19 | 0.020 |
Why?
| Breast | 1 | 2008 | 92 | 0.020 |
Why?
| Glioma | 1 | 2008 | 78 | 0.020 |
Why?
| DNA, Complementary | 1 | 2008 | 145 | 0.020 |
Why?
| Recombination, Genetic | 1 | 2008 | 108 | 0.020 |
Why?
| Aspartic Acid | 1 | 2007 | 48 | 0.020 |
Why?
| Age of Onset | 1 | 2007 | 116 | 0.020 |
Why?
| Chromosome Segregation | 1 | 2006 | 13 | 0.020 |
Why?
| Centrosome | 1 | 2006 | 11 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2006 | 180 | 0.020 |
Why?
| Glutamic Acid | 1 | 2007 | 111 | 0.020 |
Why?
| Spores, Bacterial | 1 | 2005 | 12 | 0.020 |
Why?
| Bacillus anthracis | 1 | 2005 | 11 | 0.020 |
Why?
| Bacillus subtilis | 1 | 2005 | 17 | 0.020 |
Why?
| Glutamine | 1 | 2007 | 168 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 289 | 0.020 |
Why?
| Arginine | 1 | 2007 | 182 | 0.020 |
Why?
| Genotype | 1 | 2007 | 599 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2005 | 76 | 0.020 |
Why?
| Brain Neoplasms | 1 | 2008 | 284 | 0.020 |
Why?
| Tyrosine Decarboxylase | 1 | 2004 | 1 | 0.020 |
Why?
| Hybridization, Genetic | 1 | 2004 | 8 | 0.020 |
Why?
| Heat Stress Disorders | 1 | 2004 | 19 | 0.010 |
Why?
| Locus Control Region | 1 | 2003 | 1 | 0.010 |
Why?
| Terminal Repeat Sequences | 1 | 2003 | 10 | 0.010 |
Why?
| Trinucleotide Repeats | 1 | 2002 | 3 | 0.010 |
Why?
| Codon, Initiator | 1 | 2002 | 9 | 0.010 |
Why?
| Introns | 1 | 2002 | 49 | 0.010 |
Why?
| Cohort Studies | 1 | 2007 | 1543 | 0.010 |
Why?
| Genome, Human | 1 | 2003 | 131 | 0.010 |
Why?
| Survival Analysis | 1 | 2004 | 735 | 0.010 |
Why?
| Sex Factors | 1 | 2004 | 765 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 2387 | 0.010 |
Why?
| Prospective Studies | 1 | 2007 | 2604 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 520 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2002 | 273 | 0.010 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 41 | 0.010 |
Why?
| Mammals | 1 | 2000 | 57 | 0.010 |
Why?
| Brain | 1 | 2008 | 1387 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2007 | 3429 | 0.010 |
Why?
| Risk Factors | 1 | 2007 | 3930 | 0.010 |
Why?
| Aged | 1 | 2007 | 10041 | 0.010 |
Why?
| Middle Aged | 1 | 2007 | 13070 | 0.010 |
Why?
| Adult | 1 | 2007 | 14182 | 0.010 |
Why?
|
|
Glazko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|